PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.\', \'Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.\', \'Department of Critical Care Medicine, the First Hospital of Changsha, Hunan, China.\', \'Department of Metabolism & Endocrinology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.\', \'Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education; National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.\', \'Xiangya School of Medicine, Central South University, Changsha, Hunan, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/0300060520979151
?:doi
?:hasPublicationType
?:journal
  • The Journal of international medical research
is ?:pmid of
?:pmid
?:pmid
  • 33322988
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all